Ciclopirox 3%
Product Images NDC 72934-1042

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ciclopirox 3% (NDC 72934-1042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sdf (2 End)

Sdf (2 End)
Side view of a white cylindrical container for CICLOPIROX 3% topical product by Sincerus Florida, LLC. The label includes directions for use, storage instructions at controlled room temperature, and contact information for reporting adverse reactions to the labeler. There is also a small QR code at the bottom of the label.*
FDA Label Image

Zc (1042 2 Front)

Zc (1042 2 Front)
Packaging label of CICLOPIROX OLAMINE USP 3% gel in a 30-gram container by Sincerus Florida, LLC. The label features the product's NDC 72934-1042-2 and states it is a compounded drug made in the USA. The label includes the Sincerus Florida logo with teal and orange colors.*
FDA Label Image

As (1042 2 Middle)

As (1042 2 Middle)
CICLOPIROX 3% gel container label showing active ingredient ciclopirox olamine USP 3% and inactive ingredients including ethyl alcohol USP 49%, krisgel 100 2%, and suspensisse gel 91%. The label includes manufacturing and expiration dates, lot number, and is marked Rx only. The labeler is Sincerus Florida, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.